Aker BioMarine ASA (OSL:AKBM)
Norway
· Delayed Price · Currency is NOK 89.90
+5.60 (6.64%)
Sep 29, 2025, 3:02 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Consumer Health Products | 1.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human Health Ingredients | 906.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human Health Ingredients Growth | -59.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Emerging Businesses | 104.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Brands | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Brands Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other/Elim | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other/Elim Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Americas | 1.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | -11.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific | 400.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Growth | -62.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA | 171.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | -56.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Norway | 54.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Norway Growth | -84.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|